HIV/AIDS mortality in trends in Canada, 1987-1998.
OBJECTIVE
To monitor Canadian HIV/AIDS mortality following the introduction of antiretroviral therapies in 1996, and to compare this with the US experience.


METHODS
Deaths were extracted by underlying cause of death, age, sex, marital status and place of residence at time of death. Age-specific leading causes of death, potential years of life lost before age 65, and rates are presented.


RESULTS
HIV deaths peaked in 1995 at 1,764, representing 1% of all deaths, 15% of male deaths aged 25-44, and the second leading cause of death for males age 25-44, trailing suicides. From 1995 to 1997, HIV deaths dropped by 66% for males and 43% for females. Rates for Toronto, Vancouver and Montreal were 6 times higher than in rural areas, and 2.5 times higher than in other Census Metropolitan Areas.


CONCLUSIONS
As of 1998, HIV still was a leading cause of premature mortality. The trend in Canadian HIV mortality was similar to that in the US, though US rates remain double the Canadian rates. The drop in HIV deaths may not be sustained in the long term, as antiretroviral therapy is not a cure and the number of people living with HIV is increasing.
Schanzer
Dena L
DL
Centre for Infectious Disease Prevention and Control, Population and Public Health Branch, Health Canada, AL. dena_schanzer@hc-sc.gc.ca
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D002170:Canada / Q000453:epidemiology; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000401:mortality*; D006801:Humans; D008297:Male; D009313:National Health Programs; D014481:United States / Q000453:epidemiology
D019380:Anti-HIV Agents